These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 20878737

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Mechanisms of rhabdomyolysis with statins].
    Magalhães ME.
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():42-4. PubMed ID: 16400398
    [Abstract] [Full Text] [Related]

  • 45. Muscle toxicity with statins.
    Hedenmalm K, Alvan G, Ohagen P, Dahl ML.
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC, Picksak G, Stichtenoth DO.
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [Abstract] [Full Text] [Related]

  • 48. The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.
    Chung HR, Vakil M, Munroe M, Parikh A, Meador BM, Wu PT, Jeong JH, Woods JA, Wilund KR, Boppart MD.
    PLoS One; 2016 Jan; 11(12):e0168065. PubMed ID: 27936249
    [Abstract] [Full Text] [Related]

  • 49. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G, Spatz ES, Jablecki C, Phillips PS.
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [Abstract] [Full Text] [Related]

  • 50. An assessment by the Statin Muscle Safety Task Force: 2014 update.
    Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA, The National Lipid Association's Muscle Safety Expert Panel.
    J Clin Lipidol; 2014 Jun; 8(3 Suppl):S58-71. PubMed ID: 24793443
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Reduced synthesis of coenzyme Q10 may cause statin related myopathy].
    Nielsen ML, Pareek M, Henriksen JE.
    Ugeskr Laeger; 2011 Nov 14; 173(46):2943-8. PubMed ID: 22094213
    [Abstract] [Full Text] [Related]

  • 57. Statin-induced myopathy: a review and update.
    Abd TT, Jacobson TA.
    Expert Opin Drug Saf; 2011 May 14; 10(3):373-87. PubMed ID: 21342078
    [Abstract] [Full Text] [Related]

  • 58. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
    Nichols L, Pfeifer K, Mammen AL, Shahnoor N, Konersman CG.
    J Gen Intern Med; 2015 Dec 14; 30(12):1879-83. PubMed ID: 25855481
    [Abstract] [Full Text] [Related]

  • 59. Agents and mechanisms of toxic myopathy.
    Kuncl RW.
    Curr Opin Neurol; 2009 Oct 14; 22(5):506-15. PubMed ID: 19680127
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.